EPHA3 and leukemia: Both the EphA2 mAb IF7 coupled to Lutetium-177 and then anti-EphA3 antibody IIIA4 linked to an α-particle-emitting Bismuth-213 payload showed therapeutic effect in EphA2 and EphA3 expressing leukemia models (148, 149).